Related Experiment Video
Updated: Sep 29, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
[Preparation of the promotion of therapeutic studies as an open planning process]
Abstract:
During the preparation of the government program "Health Research and Development", which was started in 1978, an attempt was made to involve the scientific community directly in establishing priorities for research on rheumatic diseases. At a planning conference open to all interested research scientists the following questions were considered: 1. What are the methodological requirements for therapeutic trials? 2. What are the open questions in the field of clinical rheumatology and which of them should be given priority? 3. What are the conditions for running multicenter therapeutic trials successfully? This paper describes the methodology and the results of the analysis of research needs and priorities and discusses the special problems of clinical rheumatology research in the Federal Republic of Germany.
Insights
This study outlines research priorities for rheumatic diseases, focusing on methodological requirements for therapeutic trials and challenges in multicenter studies. It addresses key questions to guide future clinical rheumatology research in Germany.
Area of Science:
- Rheumatology
- Medical Research Policy
Background:
- The "Health Research and Development" program initiated in 1978 aimed to integrate scientific input into research priority setting.
- Rheumatic diseases research requires strategic planning to address knowledge gaps and improve patient outcomes.
Purpose of the Study:
- To involve the scientific community in defining priorities for rheumatic diseases research.
- To identify methodological requirements for effective therapeutic trials.
- To explore conditions for successful multicenter trials in clinical rheumatology.
Main Methods:
- A planning conference was convened, open to all interested research scientists.
- Analysis of research needs and priorities was conducted.
- Discussion of specific challenges in clinical rheumatology research within the Federal Republic of Germany.
Main Results:
- Key questions regarding therapeutic trial methodology were addressed.
- Priorities for open questions in clinical rheumatology were established.
- Factors crucial for the success of multicenter therapeutic trials were identified.
Conclusions:
- The study provides a framework for prioritizing rheumatic diseases research.
- It highlights the importance of methodological rigor and collaborative efforts in clinical trials.
- Recommendations are offered for advancing rheumatology research in Germany.
Related Concept Videos
Nursing Process for Patient and Caregiver Teaching II: Planning and Implementation
Planning Nursing Care I
Clinical Trials
There are four phases in a clinical trial. A phase one...
Drug Discovery: Overview
Clinical Trials: Overview
Preclinical Development: Overview

